Laurent Roberto Chiarelli

Has grant

Associate Professor

Università degli Studi di Pavia

Italy

Research Interests

Explore related searches

Professors in Italy Professors in Microbiology Microbiology professors in Italy

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Laurent Roberto Chiarelli is an Associate Professor at Università degli Studi di Pavia, Italy. His research focuses on antimicrobial drug discovery, the biological evaluation of novel compounds, and innovative approaches to disrupt iron uptake in mycobacterial infections. Recent publications include works on phage therapy for multidrug-resistant bacteria and the design of new drug candidates targeting Mycobacterium abscessus and Mycobacterium tuberculosis.

Recent Grants

Grant: Close

Nontuberculous mycobacteria in cystic fibrosis: scouting molecules against M. abscessus iron acquisition pathways

Open Date: 2022-09-01

Close Date: 2024-08-01

Articles (24)

Year:

2026

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Collaborators (11)

Maria Rosalia PASCA

Professore Ordinario BIO/19

Università degli Studi di Pavia

ITALY

View details

GIAMPIERO PIETROCOLA

University of Pavia

ITALY

View details

Stefania Villa

ITALY

View details

Fabrizio Manetti

Professor of Medicinal Chemistry

University of Siena

ITALY

View details

Fiorella Meneghetti

University of Milan

ITALY

View details

Giovanni Stelitano

University of Pavia

ITALY

View details

Giulia Degiacomi

University of Pavia

ITALY

View details

Simona Viglio

University of Pavia

ITALY

View details

Silvia Buroni

Associate Professor

Università degli Studi di Pavia

ITALY

View details

Arianna Gelain

University of Milan

ITALY

View details

Simona Collina

University of Pavia

ITALY

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Laurent Roberto Chiarelli

Research Interests

Explore related searches

Contact this professor

About

Recent Grants

Articles (24)

Synthesis, structural characterization, and biological evaluation of cinnamaldehyde–azomethine hybrids: In Vitro and In Silico approaches

Repurposing of FDA‐Approved Drugs to Disrupt Iron Uptake in Mycobacterium abscessus: Targeting Salicylate Synthase as a Novel Approach

Artificial Intuition and accelerating the process of antimicrobial drug discovery

Artificial Intuition and accelerating the process of antimicrobial drug discovery

&lt;i&gt;Mycobacterium tuberculosis&lt;/i&gt; Sulfate Ester Dioxygenase Rv3406 Is Able to Inactivate the RCB18350 Compound.

Nanoenabling MbtI Inhibitors for Next-Generation Tuberculosis Therapy

The novel drug candidate VOMG kills Mycobacterium abscessus and other pathogens by inhibiting cell division

Phage Therapy: An Alternative Approach to Combating Multidrug-Resistant Bacterial Infections in Cystic Fibrosis

Benzothiozinone derivatives with anti-tubercular Activity-Further side chain investigation

Editorial: Enzyme targeting for the development of novel antimicrobials

Structural basis for specific inhibition of salicylate synthase from <i>Mycobacterium abs</i>cessus

Could the Oxidation of α1-Antitrypsin Prevent the Binding of Human Neutrophil Elastase in COVID-19 Patients?

CanB, a Druggable Cellular Target in Mycobacterium tuberculosis

CanB, a Druggable Cellular Target in Mycobacterium tuberculosis

Improving Protection to Prevent Bacterial Infections: Preliminary Applications of Reverse Vaccinology against the Main Cystic Fibrosis Pathogens

Side Chain-Modified Benzothiazinone Derivatives with Anti-Mycobacterial Activity

Iron Acquisition and Metabolism as a Promising Target for Antimicrobials (Bottlenecks and Opportunities): Where Do We Stand?

Iron Acquisition and Metabolism as a Promising Target for Antimicrobials (Bottlenecks and Opportunities): Where Do We Stand?

Mycobacterium abscessus Infections in Cystic Fibrosis Individuals: A Review on Therapeutic Options

Mycobacterium abscessus Infections in Cystic Fibrosis Individuals: A Review on Therapeutic Options

Targeting Siderophore-Mediated Iron Uptake in <i>M. abscessus</i>: A New Strategy to Limit the Virulence of Non-Tuberculous Mycobacteria

Structural Study of a New MbtI-Inhibitor Complex: Towards an Optimized Model for Structure-Based Drug Discovery

Structural Study of a New MbtI-Inhibitor Complex: Towards an Optimized Model for Structure-Based Drug Discovery

Could the Oxidation of a1-Antitrypsin Prevent the Binding of Human Neutrophil Elastase in COVID-19 Patients?

Collaborators (11)

Maria Rosalia PASCA

GIAMPIERO PIETROCOLA

Stefania Villa

Fabrizio Manetti

Fiorella Meneghetti

Giovanni Stelitano

Giulia Degiacomi

Simona Viglio

Silvia Buroni

Arianna Gelain

Simona Collina

Make your next move.

<i>Mycobacterium tuberculosis</i> Sulfate Ester Dioxygenase Rv3406 Is Able to Inactivate the RCB18350 Compound.